Good News for Hedge Fund Rats
Geron (GERN) a biotech company involved in Stem Cell research announced that they have seen success as human stem cells proved regenerative in the damaged hearts of rats.
The Menlo Park, Calif., biopharmaceutical company said the study’s data demonstrated that heart muscle cells derived from human embryonic stem cells improved heart...